DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Pioglitazone Hydrochloride is a drug marketed by Accord Hlthcare, Annora Pharma, Aurobindo Pharma Ltd, Celltrion, Macleods Pharms Ltd, Mylan Pharms Inc, Nostrum Labs Inc, Prinston Inc, Puracap Pharm Llc, Sandoz, Shuangcheng, Teva Pharms Usa, Torrent Pharms Ltd, Us Antibiotics, Zydus Pharms Usa Inc, and Mylan. and is included in twenty-two NDAs.
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There are forty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.
Summary for PIOGLITAZONE HYDROCHLORIDE
Recent Clinical Trials for PIOGLITAZONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Humanitas Hospital, Italy||Phase 2|
|Mario Negri Institute for Pharmacological Research||Phase 2|
|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano||Phase 2|